NCT04690829View on ClinicalTrials.gov

Biomarkers in Ocular Inflammation and Uveitis

CompletedOBSERVATIONAL

Enrollment

69

Participants

Timeline

Start Date

December 29, 2020

Primary Completion Date

November 16, 2022

Study Completion Date

November 16, 2022

Conditions

UveitisOcular Inflammation

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT04690829 - Biomarkers in Ocular Inflammation and Uveitis | Biotech Hunter | Biotech Hunter